Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy

Epilepsy Research

Volumn 110, Issue , 2015, Pages 119-131

  de Kinderen, Reina J A ^a,b,c   Postulart, Debby ^b   Aldenkamp, Albert P ^b,c,d,e   Evers, Silvia M A A ^a,f   Lambrechts, Danielle A J E ^b,d   Louw, Anton J A de ^b,d   Majoie, Marian H J M ^b,d   Grutters, Janneke P C ^g  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^f NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Economic evaluation; Intractable epilepsy; Ketogenic diet; Modeling; QALY; Vagus nerve stimulation

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HUMAN; INTRACTABLE EPILEPSY; KETOGENIC DIET; QUALITY ADJUSTED LIFE YEAR; TREATMENT RESPONSE; VAGUS NERVE STIMULATION; ADOLESCENT; COMPARATIVE STUDY; ECONOMICS; EPILEPSY; INFANT; PRESCHOOL CHILD; PROBABILITY; STATISTICAL MODEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; EPILEPSY; HUMANS; INFANT; KETOGENIC DIET; MARKOV CHAINS; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS; VAGUS NERVE STIMULATION;

EID: 84921320403     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.12.005     Document Type: Article

References (42)

1. Ben-Menachem E., Manon-Espaillat R., Ristanovic R., Wilder B.J., Stefan H., Mirza W., Tarver W.B., Wernicke J.F. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994, 35:616-626.
2. Briggs A., Claxton K., Sculpher M.J. Decision Modelling for Health Economic Evaluation 2006, Oxford University Press, Oxford.
3. Council for Public Health and Health Care Sensible and Sustainable Care 2006, Council for Public Health and Health Care, Zoetermeer, (in Dutch).
4. DeGiorgio C.M., Schachter S.C., Handforth A., Salinsky M., Thompson J., Uthman B., Reed R., Collins S., Tecoma E., Morris G.L., Vaughn B., Naritoku D.K., Henry T., Labar D., Gilmartin R., Labiner D., Osorio I., Ristanovic R., Jones J., Murphy J., Ney G., Wheless J., Lewis P., Heck C. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000, 41:1195-1200.
5. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Methods for the Economic Evaluation of Health Care Programs 2005, Oxford University Press, Oxford.
6. Dugan P., Devinsky O. Epilepsy: guidelines on vagus nerve stimulation for epilepsy. Nat. Rev. Neurol. 2013, 9:611-612.
7. Eddy D.M., Hollingworth W., Caro J.J., Tsevat J., McDonald K.M., Wong J.B. Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7. Value Health 2012, 15:843-850.
8. Evans C. The use of consensus methods and expert panels in pharmacoeconomic studies. Practical applications and methodological shortcomings. Pharmacoeconomics 1997, 12:121-129.
9. Farasat S., Kossoff E.H., Pillas D.J., Rubenstein J.E., Vining E.P., Freeman J.M. The importance of parental expectations of cognitive improvement for their children with epilepsy prior to starting the ketogenic diet. Epilepsy Behav. 2006, 8:406-410.
10. Freeman J., Veggiotti P., Lanzi G., Tagliabue A., Perucca E. The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res. 2006, 68:145-180.
11. George R., Salinsky M., Kuzniecky R., Rosenfeld W., Bergen D., Tarver W.B., Wernicke J.F. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994, 35:637-643.
12. Groves D.A., Brown V.J. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci. Biobehav. Rev. 2005, 29:493-500.
13. Guerrini R., Battini R., Ferrari A.R., Veggiotti P., Besana D., Gobbi G., Pezzani M., Berta E., Tetto A., Beghi E., Monticelli M.L., Tediosi F., Garattini L., Russo S., Rasmini P., Amadi A., Quarti P., Fabrizzi R. The costs of childhood epilepsy in Italy: comparative findings from three health care settings. Epilepsia 2001, 42:641-646.
14. Hakkaart-van Roijen L., Tan S.S., Bouwmans C.A.M. Manual for Costing Research 2010, Health Care Insurance Board, Amstelveen, (in Dutch).
15. Hallböök T., Lundgren J., Rosen I. Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia 2007, 48:59-65.
16. Hallböök T., Lundgren J., Stjernqvist K., Blennow G., Stromblad L.G., Rosen I. Vagus nerve stimulation in 15 children with therapy resistant epilepsy: its impact on cognition, quality of life, behaviour and mood. Seizure 2005, 14:504-513.
17. Handforth A., DeGiorgio C.M., Schachter S.C., Uthman B.M., Naritoku D.K., Tecoma E.S., Henry T.R., Collins S.D., Vaughn B.V., Gilmartin R.C., Labar D.R., Morris III G.L., Salinsky M.C., Osorio I., Ristanovic R.K., Labiner D.M., Jones J.C., Murphy J.V., Ney G.C., Wheless J.W. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998, 51:48-55.
18. Health Care Insurance Board Guidelines for Pharmaco-Economic Research 2006, Health Care Insurance Board, Diemen, (in Dutch).
19. Kang H.C., Hwang Y.S., Kim D.S., Kim H.D. Vagus nerve stimulation in pediatric intractable epilepsy: a Korean bicentric study. Acta Neurochir. Suppl. 2006, 99:93-96.
20. Klinkenberg S., Aalbers M.W., Vles J.S., Cornips E.M., Rijkers K., Leenen L., Kessels F.G., Aldenkamp A.P., Majoie M. Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial. Dev. Med. Child Neurol. 2012, 54:855-861.
21. Kossoff E.H., Zupec-Kania B.A., Amark P.E., Ballaban-Gil K.R., Bergqvist A.G.C., Blackford R., Buchhalter J.R., Caraballo R.H., Cross H., Dahlin M.G., Donner E.J., Klepper J., Jehle R.S., Kim H.D., Christiana Liu Y.M., Nation J., Nordli D.R., Pfeifer H.H., Rho J.M., Stafstrom C.E., Thiele E.A., Turner Z., Wirrell E.C., Wheless J.W., Veggiotti P., Vining E.P.G. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group. Epilepsia 2009, 50(2):304-317.
22. Levy R.G., Cooper P.N., Giri P. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev. 2012, 3:CD001903.
23. Majoie H.J., Berfelo M.W., Aldenkamp A.P., Renier W.O., Kessels A.G. Vagus nerve stimulation in patients with catastrophic childhood epilepsy, a 2-year follow-up study. Seizure 2005, 14:10-18.
24. Messori A., Trippoli S., Becagli P., Cincotta M., Labbate M.G., Zaccara G. Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis. Eur. J. Clin. Pharmacol. 1998, 53:421-427.
25. Morris G.L., Gloss D., Buchhalter J., Mack K.J., Nickels K., Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy. Report of the guideline development subcommittee of the American Academy of Neurology. Neurology 2013, 81(16):1453-1459.
26. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
27. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009, 50:1109-1117.
28. Privitera M.D., Welty T.E., Ficker D.M., Welge J. Vagus nerve stimulation for partial seizures. Cochrane Database Syst. Rev. 2002, (7):1-25. (CD002896).
29. Pulsifer M.B., Gordon J.M., Brandt J., Vining E.P., Freeman J.M. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev. Med. Child Neurol. 2001, 43:301-306.
30. Salinsky M.C., Uthman B.M., Ristanovic R.K., Wernicke J.F., Tarver W.B. Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. The Vagus Nerve Stimulation Study Group. Arch. Neurol. 1996, 53:1176-1180.
31. Salomon J.A., Vos T., Hogan D.R., Gagnon M., Naghavi M., Mokdad A., Begum N., Shah R., Karyana M., Kosen S., Farje M.R., Moncada G., Dutta A., Sazawal S., Dyer A., Seiler J., Aboyans V., Baker L., Baxter A., Benjamin E.J., Bhalla K., Bin Abdulhak A., Blyth F., Bourne R., Braithwaite T., Brooks P., Brugha T.S., Bryan-Hancock C., Buchbinder R., Burney P., Calabria B., Chen H., Chugh S.S., Cooley R., Criqui M.H., Cross M., Dabhadkar K.C., Dahodwala N., Davis A., Degenhardt L., Diaz-Torne C., Dorsey E.R., Driscoll T., Edmond K., Elbaz A., Ezzati M., Feigin V., Ferri C.P., Flaxman A.D., Flood L., Fransen M., Fuse K., Gabbe B.J., Gillum R.F., Haagsma J., Harrison J.E., Havmoeller R., Hay R.J., Hel-Baqui A., Hoek H.W., Hoffman H., Hogeland E., Hoy D., Jarvis D., Karthikeyan G., Knowlton L.M., Lathlean T., Leasher J.L., Lim S.S., Lipshultz S.E., Lopez A.D., Lozano R., Lyons R., Malekzadeh R., Marcenes W., March L., Margolis D.J., McGill N., McGrath J., Mensah G.A., Meyer A.C., Michaud C., Moran A., Mori R., Murdoch M.E., Naldi L., Newton C.R., Norman R., Omer S.B., Osborne R., Pearce N., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Pourmalek F., Prince M., Rehm J.T., Remuzzi G., Richardson K., Room R., Saha S., Sampson U., Sanchez-Riera L., Segui-Gomez M., Shahraz S., Shibuya K., Singh D., Sliwa K., Smith E., Soerjomataram I., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Taylor H.R., Tleyjeh I.M., van der Werf M.J., Watson W.L., Weatherall D.J., Weintraub R., Weisskopf M.G., Whiteford H., Wilkinson J.D., Woolf A.D., Zheng Z.J., Murray C.J., Jonas J.B. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012, 380:2129-2143.
32. Shahwan A., Bailey C., Maxiner W., Harvey A.S. Vagus nerve stimulation for refractory epilepsy in children: more to VNS than seizure frequency reduction. Epilepsia 2009, 50:1220-1228.
33. Sharma S., Sankhyan N., Gulati S., Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013, 54:481-486.
34. Shorvon S., Tomson T. Sudden unexpected death in epilepsy. Lancet 2011, 378:2028-2038.
35. Siebert U., Alagoz O., Bayoumi A.M., Jahn B., Owens D.K., Cohen D.J., Kuntz K.M. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force. Value Health 2012, 15:812-820.
36. Sillanpää M., Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 2006, 129:617-624.
37. Statistics Netherlands-Statline Age Related Mortality 2013, Statistics Netherlands, Derived at 10-12-2014 from http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=37530ned&D1=1&D2=101-120&D3=0&D4=l&HDR=T,G1&STB=G2,G3&VW=T
38. Suh G.H., Lee S.K. Economic evaluation of add-on levetiracetam for the treatment of refractory partial epilepsy in Korea. Psychiatry Investig. 2009, 6:185-193.
39. The Vagus Nerve Stimulation Study Group A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology 1995, 45:224-230.
40. Verdian L., Yi Y., Oyee J., Heyes A., Tolley K. Eliciting preferences for health states associated with lennox-gastaut syndrome (LGS). Poster 1, 352 Presented at the 62nd Meeting of the American Epilepsy Society 2008.
41. Weinstein M.C., O'Brien B., Hornberger J., Jackson J., Johannesson M., McCabe C., Luce B.R. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling Studies. Value Health 2003, 6(1):9-17.
42. Welte R., Feenstra T., Jager H., Leidi R. A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmaeconomics 2004, 22(13):857-876.